↓ Skip to main content

Oral rivaroxaban for Japanese patients with symptomatic venous thromboembolism – the J-EINSTEIN DVT and PE program

Overview of attention for article published in Thrombosis Journal, January 2015
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
99 Dimensions

Readers on

mendeley
78 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Oral rivaroxaban for Japanese patients with symptomatic venous thromboembolism – the J-EINSTEIN DVT and PE program
Published in
Thrombosis Journal, January 2015
DOI 10.1186/s12959-015-0035-3
Pubmed ID
Authors

Norikazu Yamada, Atsushi Hirayama, Hideaki Maeda, Satoru Sakagami, Hiroo Shikata, Martin H Prins, Anthonie WA Lensing, Masaharu Kato, Junichi Onuma, Yuki Miyamoto, Kazuma Iekushi, Mariko Kajikawa

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 78 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Chile 1 1%
Netherlands 1 1%
Slovenia 1 1%
Unknown 75 96%

Demographic breakdown

Readers by professional status Count As %
Researcher 19 24%
Other 10 13%
Student > Ph. D. Student 8 10%
Student > Master 8 10%
Student > Bachelor 7 9%
Other 10 13%
Unknown 16 21%
Readers by discipline Count As %
Medicine and Dentistry 46 59%
Pharmacology, Toxicology and Pharmaceutical Science 5 6%
Nursing and Health Professions 2 3%
Agricultural and Biological Sciences 2 3%
Arts and Humanities 1 1%
Other 3 4%
Unknown 19 24%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 25 March 2022.
All research outputs
#20,862,658
of 25,632,496 outputs
Outputs from Thrombosis Journal
#336
of 416 outputs
Outputs of similar age
#268,919
of 361,129 outputs
Outputs of similar age from Thrombosis Journal
#7
of 7 outputs
Altmetric has tracked 25,632,496 research outputs across all sources so far. This one is in the 10th percentile – i.e., 10% of other outputs scored the same or lower than it.
So far Altmetric has tracked 416 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 7.5. This one is in the 7th percentile – i.e., 7% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 361,129 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 14th percentile – i.e., 14% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 7 others from the same source and published within six weeks on either side of this one.